Pancreatic Cancer

Pancreatic cancer breakthrough ‘can help sufferers survive an extra five years’

At the moment only 5% of patients live that long, and each year in the UK 8,800 people die of the disease

Written BY ANDREW GREGORY

Pancreatic cancer survival rates have improved little since the early 1970s

A drug combination which can help pancreatic cancer sufferers survive for at least five years has been hailed as a breakthrough.

Currently, 5% of patients expect to live that long and a mere 1% are still alive 10 years after diagnosis. Survival rates have improved little since the early 1970s.

But a trial, published in the Lancet medical journal, found when chemo drugs gemcitabine and capecitabine were used together in post-op treatment, 29% lived at least five years – compared with 16% on gemcitabine alone.pancreatic cancer ag

The treatment protocol should now become the new standard of care for patients who have had surgery, experts said.

Next page

About the author

admin

Leave a Comment